Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DNA aptamer-mediated cell targeting.

Literature DB >> 23233389

DNA aptamer-mediated cell targeting.

Xiangling Xiong¹, Haipeng Liu, Zilong Zhao, Meghan B Altman, Dalia Lopez-Colon, Chaoyong James Yang, Lung-Ji Chang, Chen Liu, Weihong Tan.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 23233389 PMCID： PMC3793636 DOI： 10.1002/anie.201207063

Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN： 1433-7851 Impact factor: 15.336

× No keyword cloud information.

34 in total

1. Selecting nucleic acids for biosensor applications.

Authors: Manjula Rajendran; Andrew D Ellington
Journal: Comb Chem High Throughput Screen Date: 2002-06 Impact factor: 1.339

2. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors: C Tuerk; L Gold
Journal: Science Date: 1990-08-03 Impact factor: 47.728

Review 3. Pharmacytes: an ideal vehicle for targeted drug delivery.

Authors: Robert A Freitas
Journal: J Nanosci Nanotechnol Date: 2006 Sep-Oct

4. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors: Pierre van der Bruggen; Catia Traversari; Patrick Chomez; Christophe Lurquin; Etienne De Plaen; Benoît J Van den Eynde; Alexander Knuth; Thierry Boon
Journal: J Immunol Date: 2007-03-01 Impact factor: 5.422

5. Selection of aptamers for molecular recognition and characterization of cancer cells.

Authors: Zhiwen Tang; Dihua Shangguan; Kemin Wang; Hui Shi; Kwame Sefah; Prabodhika Mallikratchy; Hui William Chen; Ying Li; Weihong Tan
Journal: Anal Chem Date: 2007-05-27 Impact factor: 6.986

6. Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model.

Authors: Lina Elzaouk; Karin Moelling; Jovan Pavlovic
Journal: Exp Dermatol Date: 2006-11 Impact factor: 3.960

7. Cancer cell targeting using multiple aptamers conjugated on nanorods.

Authors: Yu-Fen Huang; Huan-Tsung Chang; Weihong Tan
Journal: Anal Chem Date: 2008-01-01 Impact factor: 6.986

Review 8. Drug, enzyme and peptide delivery using erythrocytes as carriers.

Authors: Carmen Gutiérrez Millán; María Luisa Sayalero Marinero; Aránzazu Zarzuelo Castañeda; José M Lanao
Journal: J Control Release Date: 2004-02-20 Impact factor: 9.776

9. Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides.

Authors: O Mandelboim; E Vadai; M Fridkin; A Katz-Hillel; M Feldman; G Berke; L Eisenbach
Journal: Nat Med Date: 1995-11 Impact factor: 53.440

10. Molecular recognition of acute myeloid leukemia using aptamers.

Authors: K Sefah; Z W Tang; D H Shangguan; H Chen; D Lopez-Colon; Y Li; P Parekh; J Martin; L Meng; J A Phillips; Y M Kim; W H Tan
Journal: Leukemia Date: 2009-01-08 Impact factor: 11.528

38 in total

1. Aptamer-Functionalized Exosomes: Elucidating the Cellular Uptake Mechanism and the Potential for Cancer-Targeted Chemotherapy.

Authors: Jianmei Zou; Muling Shi; Xiaojing Liu; Cheng Jin; Xiaojing Xing; Liping Qiu; Weihong Tan
Journal: Anal Chem Date: 2019-01-24 Impact factor: 6.986

DNA aptamer-mediated cell targeting.

1. Selecting nucleic acids for biosensor applications.

2. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Review 3. Pharmacytes: an ideal vehicle for targeted drug delivery.

4. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

5. Selection of aptamers for molecular recognition and characterization of cancer cells.

6. Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model.

7. Cancer cell targeting using multiple aptamers conjugated on nanorods.

Review 8. Drug, enzyme and peptide delivery using erythrocytes as carriers.

9. Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides.

10. Molecular recognition of acute myeloid leukemia using aptamers.

1. Aptamer-Functionalized Exosomes: Elucidating the Cellular Uptake Mechanism and the Potential for Cancer-Targeted Chemotherapy.

Review 2. Programming Cell-Cell Interactions through Non-genetic Membrane Engineering.

3. Lipid-Oligonucleotide Conjugates for Simple and Efficient Cell Membrane Engineering and Bioanalysis.

4. Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy.

5. Engineering Reversible Cell-Cell Interactions with Lipid Anchored Prosthetic Receptors.

6. Molecular Recognition-Based DNA Nanoassemblies on the Surfaces of Nanosized Exosomes.

7. Controlled Detachment of Chemically Glued Cells.

8. Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology.

9. Chimeric Aptamer-Gelatin Hydrogels as an Extracellular Matrix Mimic for Loading Cells and Growth Factors.

10. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.